IP Library Granted Patent US 8,334,367
Granted Patent B2
US 8,334,367 · App. 13/198,095 · Granted Dec 18, 2012

T2R taste receptors and genes encoding same

Assignee: Senomyx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,334,367
App. No.
13/198,095
Granted
Dec 18, 2012
Kind
B2
Abstract

Functional assays that detect the effect of a particular compound or compounds on the activation of at least one human T2R polypeptide are provided. These assays include e.g., assays which detect the effect of said compound on intracellular calcium, second messengers such as cAMP, cGMP, current e.g., by use of voltage-clamp or patch-clamp, techniques, fluorescence polarization or FRET assays, and the like. These assays are useful in identifying compounds that putatively elicit or modulate (inhibit or enhance) bitter taste in human subjects, e.g. bitter taste blockers. The effect of identified compounds on taste may be further evaluated in human or animal taste tests.

Claims (22)

1. An isolated G protein coupled receptor (GPCR) polypeptide which is at least 95% identical to the polypeptide contained in SEQ ID NO:4 or which is at least 95% identical to the entire extracellular or the transmembrane region of said polypeptide.

2. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 95% identical to the polypeptide contained in SEQ ID NO:4.

3. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 95% identical to the entire extracellular region of said polypeptide.

4. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 95% identical to the entire transmembrane region of said polypeptide.

5. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 96% identical to the polypeptide contained in SEQ ID NO:4.

6. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 96% identical to the entire extracellular region of said polypeptide.

7. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 96% identical to the entire transmembrane region of said polypeptide.

8. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 97% identical to the polypeptide contained in SEQ ID NO:4.

9. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 97% identical to the entire extracellular region of said polypeptide.

10. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 97% identical to the entire transmembrane region of said polypeptide.

11. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 98% identical to the polypeptide contained in SEQ ID NO:4.

12. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 98% identical to the entire extracellular region of said polypeptide.

13. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 98% identical to the entire transmembrane region of said polypeptide.

14. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 99% identical to the polypeptide contained in SEQ ID NO:4.

15. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 99% identical to the entire extracellular region of said polypeptide.

16. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is at least 99% identical to the entire transmembrane region of said polypeptide.

17. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is identical to the polypeptide contained in SEQ ID NO:4.

18. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is identical to the entire extracellular region of said polypeptide.

19. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is identical to the entire transmembrane region of said polypeptide.

20. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is fused to another polypeptide.

21. The isolated G protein coupled receptor (GPCR) polypeptide of claim 20 wherein the other polypeptide is a detectable marker or another G protein coupled receptor (GPCR) polypeptide.

22. The isolated G protein coupled receptor (GPCR) polypeptide of claim 1 which is immobilized on a solid support.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2019
From: ADLER, JON ELLIOT
To: SENOMYX, INC.
Reel/Frame 050329/0114 →
MERGER Recorded Sep 10, 2019
From: SENOMYX, INC.
To: FIRMENICH INCORPORATED
Reel/Frame 050329/0194 →
Continuity (6)
Division 12133155 · Jun 4, 2008
Continuation 10724209 · Dec 1, 2003
Division 09825882 · Apr 5, 2001
Provisional Application 60195532 · Apr 7, 2000
Provisional Application 60247014 · Nov 13, 2000
Related Publication 20110319602A1 · Dec 29, 2011